ArticleIndian journal of endocrinology and metabolism2011
History of growth hormone therapy.
Article in Indian journal of endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 64 citations in OpenAlex.
- Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product.Clinical pharmacology and therapeutics · 2020Trial
- Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.Journal of endocrinological investigation · 2018Trial
- Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.Journal of endocrinological investigation · 2018Trial
- Growth Hormone, Not Simply Just a Hormone for Growth.Endocrinology and metabolism (Seoul, Korea) · 2026Review
- Efficacy of Once-weekly Somatrogon in Children with Growth Hormone Deficiency After Switching from Daily TherapyEndocrine, metabolic & immune disorders drug targets · 2026Article
- A retrospective analysis of real-world height outcomes of growth hormone treatment in Syrian children.BMC endocrine disorders · 2025Article
- 'At least our pituitaries will see the world': Pituitary gland export from communist Bulgaria.Medical history · 2025Article
- Article
- Identification ofInternational journal of molecular sciences · 2025Article
- Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars-Advice to Developers and Regulatory Agencies.Biomedicines · 2025Review
- Growth hormone and aging: a clinical review.Frontiers in aging · 2025Review
- Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Humanitarian Cause.International journal of molecular sciences · 2024Review
- Transmission of amyloid-β pathology in humans: a perspective on clinical evidence.Neural regeneration research · 2024Article
- The multiple roles of GH in neural ageing and injury.Frontiers in neuroscience · 2023Review
- Interventions Designed to Improve Adherence to Growth Hormone Treatment for Pediatric Patients and Their Families: A Narrative Review.Pharmaceutics · 2022Review
- Management of Short Stature: Use of Growth Hormone in GH-Deficient and non-GH-Deficient Conditions.Indian journal of pediatrics · 2021Review
- Counseling for Growth Hormone Therapy.Turkish archives of pediatrics · 2021Article
- Effect of -202 A/C IGFBP-3 polymorphisms on growth responses in children with idiopathic short stature.Annals of pediatric endocrinology & metabolism · 2020Article
- Polymer conjugation of proteins as a synthetic post-translational modification to impact their stability and activity.Polymer chemistry · 2019Article
- Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes.European journal of clinical pharmacology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the importance of the pituitary gland for growth was recognized in late 19(th) century, Growth hormone (GH) therapy was made available for severely GH-deficient children and adolescents only in late 1950s. Use of GH for other conditions was limited because of the limited supply of human pituitary-derived hormone. With unlimited availability of recombinant human GH (rhGH), the scenario of GH treatment has been changed enormously. Currently there is ever increasing list of indications of GH treatment in children, adolescents, and adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.